Rarement, mais des complications graves peuvent affecter la qualité de vie.
Syndrome de NelsonComplications gravesQualité de vie
#3
Des complications psychologiques sont-elles possibles ?
Oui, des complications psychologiques comme la dépression peuvent survenir.
Complications psychologiquesDépressionSyndrome de Nelson
#4
Comment gérer les complications hormonales ?
La gestion implique un suivi endocrinologique et un traitement hormonal approprié.
Gestion des complicationsEndocrinologieTraitement hormonal
#5
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié.
Complications réversiblesTraitementSyndrome de Nelson
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les antécédents de maladies surrénaliennes et les traitements hormonaux sont des facteurs de risque.
Facteurs de risqueMaladies surrénaliennesTraitements hormonaux
#2
L'âge influence-t-il le risque ?
Oui, le risque augmente généralement avec l'âge, surtout après 30 ans.
ÂgeRisqueSyndrome de Nelson
#3
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux de troubles endocriniens peuvent augmenter le risque.
Antécédents familiauxTroubles endocriniensFacteurs de risque
#4
Les traitements antérieurs affectent-ils le risque ?
Oui, des traitements antérieurs pour des maladies surrénaliennes peuvent augmenter le risque.
Traitements antérieursMaladies surrénaliennesFacteurs de risque
#5
Le sexe influence-t-il le risque de syndrome ?
Des études montrent que le syndrome peut être plus fréquent chez les hommes.
SexeRisqueSyndrome de Nelson
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Nelson : Questions médicales les plus fréquentes",
"headline": "Syndrome de Nelson : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Nelson : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2026-01-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Nelson"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adénome à ACTH",
"url": "https://questionsmedicales.fr/mesh/D049913",
"about": {
"@type": "MedicalCondition",
"name": "Adénome à ACTH",
"code": {
"@type": "MedicalCode",
"code": "D049913",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.700.734.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Nelson",
"alternateName": "Nelson Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D009347",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Niki Karavitaki",
"url": "https://questionsmedicales.fr/author/Niki%20Karavitaki",
"affiliation": {
"@type": "Organization",
"name": "Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, IBR Tower, Level 2, Birmingham, B15 2TT, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK; Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. Electronic address: n.karavitaki@bham.ac.uk."
}
},
{
"@type": "Person",
"name": "Bartosz Skalski",
"url": "https://questionsmedicales.fr/author/Bartosz%20Skalski",
"affiliation": {
"@type": "Organization",
"name": "Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Łódź, Pomorska 141/3, 90-236, Łódź, Poland."
}
},
{
"@type": "Person",
"name": "Beata Olas",
"url": "https://questionsmedicales.fr/author/Beata%20Olas",
"affiliation": {
"@type": "Organization",
"name": "Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Łódź, Pomorska 141/3, 90-236, Łódź, Poland. beata.olas@biol.uni.lodz.pl."
}
},
{
"@type": "Person",
"name": "Anna Stochmal",
"url": "https://questionsmedicales.fr/author/Anna%20Stochmal",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100, Puławy, Poland."
}
},
{
"@type": "Person",
"name": "Jerzy Żuchowski",
"url": "https://questionsmedicales.fr/author/Jerzy%20%C5%BBuchowski",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100, Puławy, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37141412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18632/oncotarget.28409"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de l'hypophyse",
"item": "https://questionsmedicales.fr/mesh/D010900"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs de l'hypophyse",
"item": "https://questionsmedicales.fr/mesh/D010911"
},
{
"@type": "ListItem",
"position": 5,
"name": "Adénome à ACTH",
"item": "https://questionsmedicales.fr/mesh/D049913"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syndrome de Nelson",
"item": "https://questionsmedicales.fr/mesh/D009347"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Nelson - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Nelson",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Nelson",
"description": "Comment diagnostique-t-on le syndrome de Nelson ?\nQuels tests hormonaux sont utilisés ?\nL'IRM est-elle toujours nécessaire ?\nQuels signes cliniques indiquent le syndrome ?\nPeut-on confondre ce syndrome avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Nelson",
"description": "Quels sont les symptômes principaux du syndrome de Nelson ?\nLa perte de vision est-elle fréquente ?\nY a-t-il des symptômes psychologiques associés ?\nComment l'hyperpigmentation se manifeste-t-elle ?\nLes symptômes varient-ils d'un patient à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Nelson",
"description": "Peut-on prévenir le syndrome de Nelson ?\nLes patients à risque doivent-ils être surveillés ?\nY a-t-il des facteurs de risque identifiables ?\nLes examens réguliers sont-ils utiles ?\nL'éducation des patients est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Nelson",
"description": "Quel est le traitement principal du syndrome de Nelson ?\nDes médicaments sont-ils utilisés ?\nLa radiothérapie est-elle une option ?\nQuels sont les effets secondaires des traitements ?\nLe suivi est-il nécessaire après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Nelson",
"description": "Quelles complications peuvent survenir ?\nLe syndrome de Nelson peut-il être fatal ?\nDes complications psychologiques sont-elles possibles ?\nComment gérer les complications hormonales ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Nelson",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes traitements antérieurs affectent-ils le risque ?\nLe sexe influence-t-il le risque de syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D009347?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome de Nelson ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests hormonaux et des IRM de l'hypophyse."
}
},
{
"@type": "Question",
"name": "Quels tests hormonaux sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On mesure les niveaux d'ACTH et de cortisol dans le sang."
}
},
{
"@type": "Question",
"name": "L'IRM est-elle toujours nécessaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM est recommandée pour visualiser les tumeurs hypophysaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent le syndrome ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des maux de tête et des troubles visuels peuvent indiquer le syndrome."
}
},
{
"@type": "Question",
"name": "Peut-on confondre ce syndrome avec d'autres ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres troubles hypophysaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome de Nelson ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, une hyperpigmentation et des troubles visuels."
}
},
{
"@type": "Question",
"name": "La perte de vision est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de vision peut survenir en raison de la pression sur le nerf optique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de l'humeur et de l'anxiété peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment l'hyperpigmentation se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des taches sombres sur la peau, surtout dans les plis."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'un patient à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le syndrome de Nelson ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour ce syndrome."
}
},
{
"@type": "Question",
"name": "Les patients à risque doivent-ils être surveillés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est recommandée pour les patients ayant subi une surrénalectomie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque identifiables ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies surrénaliennes augmentent le risque de syndrome de Nelson."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des anomalies précoces."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les symptômes peut aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome de Nelson ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est chirurgical pour retirer la tumeur hypophysaire."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour contrôler les niveaux d'ACTH."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée si la chirurgie n'est pas suffisante."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées et troubles hormonaux."
}
},
{
"@type": "Question",
"name": "Le suivi est-il nécessaire après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les niveaux hormonaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles visuels permanents et des déséquilibres hormonaux."
}
},
{
"@type": "Question",
"name": "Le syndrome de Nelson peut-il être fatal ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais des complications graves peuvent affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques sont-elles possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications hormonales ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi endocrinologique et un traitement hormonal approprié."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies surrénaliennes et les traitements hormonaux sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout après 30 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles endocriniens peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les traitements antérieurs affectent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements antérieurs pour des maladies surrénaliennes peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de syndrome ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le syndrome peut être plus fréquent chez les hommes."
}
}
]
}
]
}
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, IBR Tower, Level 2, Birmingham, B15 2TT, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK; Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. Electronic address: n.karavitaki@bham.ac.uk.
Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Łódź, Pomorska 141/3, 90-236, Łódź, Poland. beata.olas@biol.uni.lodz.pl.
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, IBR Tower, Level 2, Birmingham, B15 2TT, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK; Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Department of Family Medicine, Faculty of Health Science, Walter Sisulu University, Port Elizabeth, South Africa; and, Department of Family Medicine, Dora Nginza Provincial Hospital, Port Elizabeth. adeyinkaalabi@yahoo.com.
Department of Pathogenic Microbiology, College of Basic Medical Sciences, Jinzhou Medical University, No. 40, the Third Section of SongPo Rd, Jinzhou City, 121200, Liaoning Province, China.
Department of Pathogenic Microbiology, College of Basic Medical Sciences, Jinzhou Medical University, No. 40, the Third Section of SongPo Rd, Jinzhou City, 121200, Liaoning Province, China.
Department of Pathogenic Microbiology, College of Basic Medical Sciences, Jinzhou Medical University, No. 40, the Third Section of SongPo Rd, Jinzhou City, 121200, Liaoning Province, China.
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...